Literature DB >> 19390307

Clinical manifestations and natural history of Hodgkin's lymphoma.

Joseph M Connors1.   

Abstract

Hodgkin's lymphoma usually presents with typical lymphadenopathy that has been detected either incidentally by the patient or by imaging procedures performed for assessment of other conditions. Occasionally, it may be detected when investigation of nonspecific symptoms, such as fever, fatigue, or unexplained pain prompt assessment that, in turn reveals a mass lesion. The diagnosis must be confirmed with an appropriate biopsy. Nowadays, clinicians usually have little difficulty making the diagnosis of Hodgkin's lymphoma. Knowledge of the usual pattern of spread of this lymphoma, with its orderly progression through lymph node groups and its typical forms of extranodal involvement, facilitates timely diagnosis, staging, and treatment planning. Rare manifestations due to involvement of unusual sites or presentation with paraneoplastic organ dysfunction can prove challenging but a search for mass lesions and an appreciation of these uncommonly encountered findings as potential clues to the presence of Hodgkin's lymphoma usually prompts appropriate investigation and correct diagnosis. Finally, an understanding of the usual pattern and timing of relapse and knowledge of the typical types of late toxicity expected after successful eradication of the lymphoma allow the patient's physicians to detect recurrence in a timely fashion and to identify or prevent secondary complications enabling appropriate management plans to be developed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390307     DOI: 10.1097/PPO.0b013e3181a282d8

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  13 in total

1.  Hodgkin lymphoma in pregnancy.

Authors:  Veronika Bachanova; Joseph M Connors
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

2.  Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.

Authors:  Neetha Gandikota; Sidonie Hartridge-Lambert; Jocelyn C Migliacci; Joachim Yahalom; Carol S Portlock; Heiko Schöder
Journal:  Cancer       Date:  2015-03-04       Impact factor: 6.860

3.  Paraneoplastic eczematous eruption associated with Hodgkin's lymphoma.

Authors:  Usman Asad; Brett Austin; Ashley Sturgeon; Cloyce Stetson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-05

4.  Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.

Authors:  Diponkar Banerjee
Journal:  Adv Hematol       Date:  2011-01-18

Review 5.  The role of radiotherapy in Hodgkin's lymphoma: what has been achieved during the last 50 years?

Authors:  Magdalena Witkowska; Agata Majchrzak; Piotr Smolewski
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

6.  Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report.

Authors:  Caren L Hughes; Jeffrey T Yorio; Craig Kovitz; Yasuhiro Oki
Journal:  J Med Case Rep       Date:  2014-12-21

7.  Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity.

Authors:  Gang Wang; Da-Ming Zhang; Hai-Ying Zhuang; Chao Yin; Jing Liu; Zi-Chun Wang; Li-Cheng Cai; Ming-Hua Ren; Wan-Hai Xu; Cheng Zhang
Journal:  Chin Med J (Engl)       Date:  2017-09-20       Impact factor: 2.628

Review 8.  Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).

Authors:  Marius Goldkuhle; Maria Dimaki; Gerald Gartlehner; Ina Monsef; Philipp Dahm; Jan-Peter Glossmann; Andreas Engert; Bastian von Tresckow; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2018-07-12

9.  Secondary Sclerosing Cholangitis and Hodgkin's Lymphoma.

Authors:  Seyed Hassan Abedi; Maryam Ghassami; Mahsa Molaei; Zhaleh Mohsenifar; Amir Houshang Mohammad Alizadeh
Journal:  Clin Med Insights Case Rep       Date:  2015-09-03

10.  Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkin's Lymphoma Patients with Chemotherapy Regimens.

Authors:  Ahmad Ahmadzadeh; Mir Saeed Yekaninejad; Mohamad H Jalili; Mohammad Bahadoram; Mehdi Efazat; Mohammad Seghatoleslami; Fatemeh Yazdi; Mozhdeh Mahdipour; Armita Valizadeh; Najmaldin Saki
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.